Iveda Announces Pricing of $2 Million Public Offering

Core Viewpoint - Iveda announced a public offering of 5,714,286 shares of common stock and series X warrants, priced at $0.35 per share, aiming to raise approximately $2.0 million for general corporate purposes [1][3]. Group 1: Offering Details - The public offering includes 5,714,286 shares of common stock or pre-funded warrants and series X warrants to purchase up to 11,428,572 shares [1]. - The series X warrants will have an exercise price of $0.35 per share, exercisable immediately upon issuance, and will expire two years from the date of issuance [1]. - The closing of the offering is expected on or about February 11, 2026, subject to customary closing conditions [1]. Group 2: Financial Proceeds and Use - The gross proceeds from the offering are expected to be approximately $2.0 million before deducting fees and expenses [3]. - The net proceeds will be used for general corporate purposes, which may include research and development, repayment of existing debt, working capital, capital expenditures, acquisitions, joint ventures, and stock repurchase programs [3]. Group 3: Regulatory Information - A registration statement on Form S-1 was declared effective by the SEC on February 9, 2026, and the offering is being made only by means of a prospectus [4].